Analysis of Inhaled Corticoid Prescriptions in General Medicine

Completed

• Conditions: Asthma; Chronic Obstructive Pulmonary Disease

• Registration Number: NCT03179826
• Lead Sponsor: University Hospital, Montpellier

Brief Summary

Chronic obstructive pulmonary disease (COPD) and asthma are frequent and disabling pathologies. The general practitioner is often at the front line vis-a-vis screening, diagnosis and treatment of these pathologies. There are currently many treatments available, in particular inhaled corticosteroids, and although the recommendations for management appear to be well codified in theory, the adaptation of drug therapy remains complex in general practice.

The prescription of inhaled corticosteroids, often initiated during a general medicine consultation, is not simple. The aim of this study is to analyze the relevance of the prescription of inhaled corticosteroids in primary care and to identify the criteria necessary for the prescription of inhaled corticosteroids available in general practice.

The main objective of our study is to evaluate the rate of consultations where all the elements required for guiding the prescription of an inhaled corticoid are available.

The secondary objectives are:

* Identify other factors associated with decision-making

* Identify the causes of inhaled corticosteroid stopping (de-prescription)

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2017-06-06
• Study First Submitted QC: 2017-06-06
• Study First Posted: 2017-06-07
• Study Start: 2017-07-13
• Primary Completion: 2018-07-01
• Study Completion: 2018-12-31
• Status Verified: 2019-04
• Last Update Submitted: 2019-04-17
• Last Update Posted: 2019-04-18

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

• Patient with short-term inhaled corticosteroid therapy
• Informed and not opposed to participate in this research

Exclusion Criteria

• Patient under judicial or legal protection
• Adults under any kind of guardianship -

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Presence of all factors justifying the prescription of inhaled cortcoids	Day 0 (transversal study)	The presence (yes/no) of all factors justifying the prescription of inhaled cortcoids as described in the associated market authorization.

Trial Locations

Locations (1)

Cabinet de médecine générale; 🇫🇷 St Martin de Londres, France